>
Switch to:

Eidos Therapeutics Pre-Tax Income

: $-100.83 Mil (TTM As of Sep. 2020)
View and export this data going back to 2018. Start your Free Trial

Pretax income is the income that a company earns before paying income taxes. Eidos Therapeutics's pretax income for the three months ended in Sep. 2020 was $-30.18 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2020 was $-100.83 Mil. Eidos Therapeutics's pretax margin was -23,760.63%.

During the past 4 years, Eidos Therapeutics's highest Pretax Margin was -141.75%. The lowest was -79392.91%. And the median was -141.75%.

Eidos Therapeutics Pre-Tax Income Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Eidos Therapeutics Annual Data
Dec16 Dec17 Dec18 Dec19
Pre-Tax Income -2.54 -11.94 -40.73 -37.84

Eidos Therapeutics Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Pre-Tax Income Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.93 -18.98 -22.82 -28.85 -30.18
Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.

Eidos Therapeutics Pre-Tax Income Distribution

* The bar in red indicates where Eidos Therapeutics's Pre-Tax Income falls into.


Eidos Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Eidos Therapeutics's Pretax Income for the fiscal year that ended in Dec. 2019 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-40.451+2.943+-0.327+0+0
=-37.84

Eidos Therapeutics's Pretax Income for the quarter that ended in Sep. 2020 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-29.403+-0.007+-0.766+0+0
=-30.18

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2020 was -18.98 (Dec. 2019 ) + -22.824 (Mar. 2020 ) + -28.849 (Jun. 2020 ) + -30.176 (Sep. 2020 ) = $-100.83 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Eidos Therapeutics  (NAS:EIDX) Pre-Tax Income Explanation

Eidos Therapeutics's Pretax Margin for the quarter that ended in Sep. 2020 is calculated as

Pretax Margin=Pretax Income/Revenue
=-30.176/0.127
=-23,760.63%

During the past 4 years, Eidos Therapeutics's highest Pretax Margin was -141.75%. The lowest was -79392.91%. And the median was -141.75%.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Eidos Therapeutics Pre-Tax Income Related Terms

Eidos Therapeutics Pre-Tax Income Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)